Drug: TYSABRI Injury: Mobility decreased Quarter: 2016Q3
Total Records: 34 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 118897767 | TYSABRI | Mobility decreased | BIOGEN | 33.00 YR | F | 85 KG | 20160708 | CO |
| 120106713 | TYSABRI | Mobility decreased | BIOGEN | 58.07 YR | F | 0 | 20160801 | US |
| 122041775 | TYSABRI | Mobility decreased | BIOGEN | 39.75 YR | F | 0 | 20160721 | US |
| 122506253 | TYSABRI | Mobility decreased | BIOGEN | 0.00 | F | 0 | 20160728 | US |
| 122770183 | TYSABRI | Mobility decreased | BIOGEN | 0.00 | F | 0 | 20160719 | GB |
| 123866064 | TYSABRI | Mobility decreased | BIOGEN | 50.60 YR | F | 0 | 20160726 | US |
| 124662102 | TYSABRI | Mobility decreased | BIOGEN | 50.69 YR | F | 0 | 20160729 | US |
| 125498732 | TYSABRI | Mobility decreased | BIOGEN | 31.95 YR | F | 0 | 20160725 | NZ |
| 125506623 | TYSABRI | Mobility decreased | BIOGEN | 63.11 YR | F | 0 | 20160823 | US |
| 125515231 | TYSABRI | Mobility decreased | BIOGEN | 0.00 | F | 0 | 20160713 | US |
| 125527814 | TYSABRI | Mobility decreased | BIOGEN | 45.09 YR | F | 0 | 20160921 | US |
| 125683232 | TYSABRI | Mobility decreased | BIOGEN | 52.44 YR | F | 0 | 20160725 | US |
| 125722661 | TYSABRI | Mobility decreased | BIOGEN | 0.00 | M | 0 | 20160719 | US |
| 125775102 | TYSABRI | Mobility decreased | BIOGEN | 0.00 | M | 0 | 20160801 | US |
| 125783191 | TYSABRI | Mobility decreased | BIOGEN | 0.00 | F | 0 | 20160721 | US |
| 125812701 | TYSABRI | Mobility decreased | BIOGEN | 55.42 YR | M | 0 | 20160721 | US |
| 125845481 | TYSABRI | Mobility decreased | BIOGEN | 0.00 | F | 0 | 20160722 | US |
| 126066531 | TYSABRI | Mobility decreased | BIOGEN | 0.00 | F | 0 | 20160729 | US |
| 126102031 | TYSABRI | Mobility decreased | BIOGEN | 0.00 | F | 0 | 20160801 | US |
| 126280841 | TYSABRI | Mobility decreased | BIOGEN | 30.17 YR | F | 0 | 20160808 | US |
Total Records: 34 Number of Pages: 2